首頁 > 市場調查報告書 > 製藥

循環系統

慢性靜脈阻塞治療市場規模、佔有率和成長分析：按治療方法、疾病、應用、最終用戶、手術、患者群體和地區分類－2026年至2033年產業預測

市場調查報告書

商品編碼

2048803

慢性靜脈阻塞治療市場規模、佔有率和成長分析：按治療方法、疾病、應用、最終用戶、手術、患者群體和地區分類－2026年至2033年產業預測

Chronic Venous Occlusions Treatment Market Size, Share, and Growth Analysis, By Treatment Type, By Disease Type, By Application, By End User, By Procedure Type, By Patient Type, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球慢性靜脈阻塞治療市場價值為 69 億美元，預計從 2025 年的 72.2 億美元成長到 2033 年的 104.3 億美元，預測期（2026-2033 年）複合年成長率為 4.7%。

慢性靜脈阻塞治療市場的成長主要受靜脈疾病盛行率上升的驅動，尤其是在老年人和合併其他疾病的人中，這導致對微創解決方案的需求不斷成長。該市場涵蓋旨在診斷和開通阻塞靜脈的醫療設備、影像系統和手術。這是因為未經治療的疾病會導致劇烈疼痛、生活品質下降以及長期醫療成本增加。血管內治療設備的創新顯著提高了血管通暢率，從而推動了新產品的研發。這使得醫療機構能夠擴展治療方案。此外，人工智慧的進步透過影像分析的自動化和手術策略的最佳化，簡化了治療計劃，從而在不同的醫療環境中提供更有效率、更個人化的患者照護。

全球慢性靜脈阻塞治療市場促進因素

靜脈疾病及其併發症的日益普遍，導致尋求介入治療的患者群體不斷擴大，進而造成慢性靜脈阻塞治療需求的持續成長。隨著臨床醫生在保守治療無效時擴大推薦介入治療，專用器械和一次性耗材的使用量也在增加。這種不斷成長的臨床需求促使製造商專注於產品創新和市場推廣，加速治療方案的拓展和在各類醫療機構中的應用。醫護人員和患者對相關疾病意識提升也影響轉診模式，改變了治療路徑，並透過增加手術量和技術應用，促進了市場成長。

全球慢性靜脈阻塞治療市場面臨的限制因素

全球慢性靜脈阻塞治療市場面臨許多限制因素，阻礙其發展。專用設備、手術器械和手術全期護理的高成本可能會阻礙醫院和診所採用這些治療方法，從而導致提供先進治療方案的機構數量減少。預算限制往往迫使管理者優先考慮那些被認為更有益或報銷率更高的服務，這可能會延遲對新技術和培訓的投資。此外，面臨成本增加和報銷限制的患者可能不太願意接受介入治療，這進一步降低了臨床醫生和患者的積極性，儘管臨床需求明確，從而阻礙了市場成長。

慢性靜脈阻塞治療市場的全球趨勢

全球慢性靜脈阻塞治療市場正經歷微創器材創新方面的顯著趨勢。這一轉變的特點是引入了更小的導管、軟性支架結構和生物可吸收材料，所有這些都旨在減少手術併發症並縮短患者恢復時間。重點在於提高靶向輸送的精準度和影像相容性，同時適應不同的靜脈解剖結構，這正在推動醫療機構對這些器械的採用。醫療設備製造商和臨床醫生之間日益密切的合作正在加速這一進程，而新的證據支持了器械的安全性和功能性療效。因此，市場正轉向門診和日間手術干預，並著重根據醫療設備在臨床環境中的實際應用性對其進行差異化區分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Boston Scientific
Medtronic
BD
Cook Medical
Philips Healthcare
B. Braun
Terumo Corporation
Johnson & Johnson
Abbott Laboratories
AngioDynamics
Cordis
Merit Medical Systems
Penumbra
Inari Medical
Vesper Medical
WL Gore & Associates
Veniti
OptiMed
Blue Sail Medical
BIOTRONIK

結論與建議

簡介目錄

Product Code: SQMIG35I2617

Global Chronic Venous Occlusions Treatment Market size was valued at USD 6.9 Billion in 2024 and is poised to grow from USD 7.22 Billion in 2025 to USD 10.43 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The growth of the chronic venous occlusions treatment market is primarily fueled by the increasing prevalence of venous diseases, particularly among aging populations and individuals with comorbidities, leading to a heightened demand for minimally invasive solutions. This market encompasses devices, imaging systems, and procedures aimed at diagnosing and reopening occluded veins, as untreated conditions can result in severe pain and diminished quality of life, contributing to increased long-term healthcare expenses. Innovations in endovascular devices have significantly enhanced vessel patency, fostering a surge in new product development, which, in turn, encourages healthcare providers to expand treatment programs. Additionally, advancements in AI streamline treatment planning by automating image analysis and optimizing procedural strategies, ultimately promoting efficiency and personalization in patient care pathways across diverse healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chronic Venous Occlusions Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chronic Venous Occlusions Treatment Market Segments Analysis

Global chronic venous occlusions treatment market is segmented by by treatment type, by disease type, by application, by end user, by procedure type, by patient type and region. Based on by treatment type, the market is segmented into Endovascular Treatment, Surgical Treatment, Pharmacological Treatment and Compression Therapy. Based on by disease type, the market is segmented into Iliac Vein Occlusion, Femoral Vein Occlusion, Inferior Vena Cava Occlusion, Post-thrombotic Syndrome and Others. Based on by application, the market is segmented into Deep Vein Occlusion Treatment, Chronic Venous Insufficiency Management, Post-thrombotic Syndrome Management and Others. Based on by end user, the market is segmented into Hospitals, Specialty Vascular Clinics, Ambulatory Surgical Centers and Others. Based on by procedure type, the market is segmented into Minimally Invasive Procedures and Open Surgical Procedures. Based on by patient type, the market is segmented into Adult and Geriatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chronic Venous Occlusions Treatment Market

The rising prevalence of venous diseases and their associated complications has broadened the patient base seeking interventional treatments, leading to a consistent demand for chronic venous occlusion therapies. As clinicians increasingly recommend procedural interventions when conservative treatments fail, the use of specialized devices and single-use consumables is on the rise. This heightened clinical demand encourages manufacturers to focus on product innovation and market introduction, expanding treatment options and fostering adoption in various healthcare settings. Enhanced awareness among both providers and patients also influences referral patterns, transforming treatment pathways and contributing to market growth through increased procedural volumes and technology utilization.

Restraints in the Global Chronic Venous Occlusions Treatment Market

The global market for chronic venous occlusions treatment faces several constraints that hinder its advancement. High costs associated with specialized devices, procedural instruments, and perioperative care can discourage hospitals and clinics from adopting these treatments, resulting in fewer facilities offering advanced options. Budgetary constraints often lead administrators to prioritize services that are perceived as more beneficial or better reimbursed, causing delays in investing in new technologies and training. Moreover, patients facing increased expenses and reimbursement limitations may be less inclined to pursue interventional care, further dampening enthusiasm among clinicians and patients alike and stifling market growth despite the evident clinical demand.

Market Trends of the Global Chronic Venous Occlusions Treatment Market

The Global Chronic Venous Occlusions Treatment market is witnessing a significant trend towards minimally invasive device innovation. This shift is characterized by the introduction of smaller-profile catheters, flexible stent architectures, and bioresorbable materials, all aimed at reducing procedural complications and enhancing patient recovery times. The focus is on improving targeted delivery and imaging compatibility, while accommodating diverse venous anatomies, which facilitates broader adoption among healthcare providers. Increased collaboration between device manufacturers and clinicians is accelerating advancements, bolstered by emerging evidence supporting both safety and functional outcomes. Consequently, the market is leaning towards outpatient and day-case interventions, emphasizing device differentiation based on practical usability in clinical settings.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Chronic Venous Occlusions Treatment Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Endovascular Treatment
- Venous Stenting
- Balloon Angioplasty
- Catheter-directed Thrombolysis
- Mechanical Thrombectomy
- Others
Surgical Treatment
- Venous Bypass Surgery
- Endophlebectomy
- Others
Pharmacological Treatment
- Anticoagulants
- Thrombolytic Drugs
- Others
Compression Therapy

Global Chronic Venous Occlusions Treatment Market Size by Disease Type & CAGR (2026-2033)

Market Overview
Iliac Vein Occlusion
Femoral Vein Occlusion
Inferior Vena Cava Occlusion
Post-thrombotic Syndrome
Others

Global Chronic Venous Occlusions Treatment Market Size by Application & CAGR (2026-2033)

Market Overview
Deep Vein Occlusion Treatment
Chronic Venous Insufficiency Management
Post-thrombotic Syndrome Management
Others

Global Chronic Venous Occlusions Treatment Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Vascular Clinics
Ambulatory Surgical Centers
Others

Global Chronic Venous Occlusions Treatment Market Size by Procedure Type & CAGR (2026-2033)

Market Overview
Minimally Invasive Procedures
Open Surgical Procedures

Global Chronic Venous Occlusions Treatment Market Size by Patient Type & CAGR (2026-2033)

Market Overview
Adult
Geriatric

Global Chronic Venous Occlusions Treatment Market Size & CAGR (2026-2033)

North America (By Treatment Type, By Disease Type, By Application, By End User, By Procedure Type, By Patient Type)
- US
- Canada
Europe (By Treatment Type, By Disease Type, By Application, By End User, By Procedure Type, By Patient Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (By Treatment Type, By Disease Type, By Application, By End User, By Procedure Type, By Patient Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (By Treatment Type, By Disease Type, By Application, By End User, By Procedure Type, By Patient Type)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (By Treatment Type, By Disease Type, By Application, By End User, By Procedure Type, By Patient Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vesper Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veniti
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptiMed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Blue Sail Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments